Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APREMEC: Aspirin for Prevention of Postsurgical Recurrence in Colorectal Cancer
NCT02607072Phase 3Unknown
- Sponsor
- Fourth Affiliated Hospital of Anhui Medical University
- Start
- Oct 2015
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aspirin in colorectal cancer (CRC) (3 arms), sponsored by Fourth Affiliated Hospital of Anhui Medical University. Primary endpoint: Disease-Free Survival at 3 years. Status: unknown.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02607072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02607072.